Inventor
NAGORSEN DIRK
DE11 patents
⚠️ This page may combine multiple inventors who share the name “NAGORSEN DIRK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMGEN RES MUNICH GMBH
7 patentsUS9688760B2Jun 27, 2017
Anti-leukocyte adhesion for the mitigation of potential adverse events caused by CD3-specific binding domains
AMGEN RES MUNICH GMBH17 citations90
US10662243B2May 26, 2020
Dosage regimen for administering a CD19XCD3 bispecific antibody
AMGEN RES MUNICH GMBH6 citations82
US10696744B2Jun 30, 2020
Means and methods for treating DLBCL
AMGEN RES MUNICH GMBH3 citations72
US11084876B2Aug 10, 2021
Anti-leukocyte adhesion for the mitigation of potential adverse events caused by CD3-specific binding domains
AMGEN RES MUNICH GMBH4 citations71
US9486475B2Nov 8, 2016
PPS for the prevention of potential adverse effects caused by CD3 specific binding domains
AMGEN RES MUNICH GMBH4 citations71
US11633408B2Apr 25, 2023
Prevention of adverse effects caused by CD3 specific binding domains
AMGEN RES MUNICH GMBH0 citations61
US11579142B2Feb 14, 2023
Dosage regimen for administering a CD19xCD3 bispecific antibody to patients at risk for potential adverse effects
AMGEN RES MUNICH GMBH0 citations61